Analysts Viewpoint
BEAM’s short interest reaches 21.73 million shares on 2025-06-13
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Beam Therapeutics Inc’s recently made public that its Chief Legal Officer Bellon Christine unloaded Company’s shares for reported $0.1 million
In a filing, Beam Therapeutics Inc revealed its Chief Legal Officer Bellon Christine unloaded Company’s shares for reported $0.1 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Beam Therapeutics Inc’s recently made public that its Chief Legal Officer Bellon Christine unloaded Company’s shares for reported $0.1 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Beam Therapeutics
Beam Therapeutics Inc’s filing revealed that its Chief Legal Officer Bellon Christine unloaded Company’s shares for reported $0.1 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Beam Therapeutics